These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16423162

  • 1. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study.
    Haro JM, van Os J, Vieta E, Reed C, Lorenzo M, Goetz I, EMBLEM Advisory Board.
    Acta Psychiatr Scand; 2006 Feb; 113(2):112-20. PubMed ID: 16423162
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M, EMBLEM Advisory Board.
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [Abstract] [Full Text] [Related]

  • 3. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 4. Stability and treatment outcome of distinct classes of mania.
    van Rossum I, Haro JM, Tenback D, Boomsma M, Goetz I, Vieta E, van Os J, EMBLEM Advisory Board.
    Eur Psychiatry; 2008 Aug; 23(5):360-7. PubMed ID: 18434101
    [Abstract] [Full Text] [Related]

  • 5. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D, European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board.
    J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and clinical presentation of HIV positive female psychiatric inpatients.
    Uys H.
    Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):23-8. PubMed ID: 23417632
    [Abstract] [Full Text] [Related]

  • 7. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM).
    Van Riel WG, Vieta E, Martinez-Aran A, Haro JM, Bertsch J, Reed C, Van Os J.
    World J Biol Psychiatry; 2008 Jan; 9(4):313-20. PubMed ID: 18949649
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
    Gonzalez-Pinto A, Vieta E, Reed C, Novick D, Barraco A, Aguado J, Haro JM.
    J Affect Disord; 2011 Jun; 131(1-3):320-9. PubMed ID: 21195486
    [Abstract] [Full Text] [Related]

  • 9. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK, Porsdal V, Aarre TF, Koponen HJ, Aarnio J, Kleivenes OK, Emblem Advisory Board.
    Nord J Psychiatry; 2009 Jun; 63(4):285-91. PubMed ID: 19140076
    [Abstract] [Full Text] [Related]

  • 10. Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication.
    Azorin JM, Aubrun E, Bertsch J, Reed C, Gerard S, Lukasiewicz M.
    BMC Psychiatry; 2009 Jun 07; 9():33. PubMed ID: 19500417
    [Abstract] [Full Text] [Related]

  • 11. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE, Leverich GS, Post RM.
    Am J Psychiatry; 2004 Aug 07; 161(8):1447-54. PubMed ID: 15285972
    [Abstract] [Full Text] [Related]

  • 12. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
    Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J, EMBLEM Advisory Board.
    J Psychiatr Res; 2008 Oct 07; 42(13):1068-75. PubMed ID: 18262204
    [Abstract] [Full Text] [Related]

  • 13. [Management of patients with acute manic or mixed episodes and outcome at three months].
    Azorin JM, Luquiens A, Aubrun E, Reed C, Gasquet I, Lukasiewicz M.
    Encephale; 2010 Jun 07; 36(3):226-35. PubMed ID: 20620265
    [Abstract] [Full Text] [Related]

  • 14. Treatment response in nonpsychotic vs psychotic manias - A follow up study from India.
    Prabhavathy KS, Kuruvilla PK, Ravindren R, Ganesh KK, Midhun S.
    Asian J Psychiatr; 2017 Apr 07; 26():104-108. PubMed ID: 28483069
    [Abstract] [Full Text] [Related]

  • 15. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
    Bellantuono C, Barraco A, Rossi A, Goetz I.
    BMC Psychiatry; 2007 Jul 19; 7():33. PubMed ID: 17640381
    [Abstract] [Full Text] [Related]

  • 16. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF, Noordsy DL, Xie H, Drake RE.
    Psychiatr Serv; 2003 Oct 19; 54(10):1395-401. PubMed ID: 14557527
    [Abstract] [Full Text] [Related]

  • 17. Factors associated with pharmacologic noncompliance in patients with mania.
    Keck PE, McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, Bennett JA, Tugrul KC, West SA.
    J Clin Psychiatry; 1996 Jul 19; 57(7):292-7. PubMed ID: 8666570
    [Abstract] [Full Text] [Related]

  • 18. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
    Tohen M, Zarate CA, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ.
    Am J Psychiatry; 2003 Dec 19; 160(12):2099-107. PubMed ID: 14638578
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of short-term olanzapine in patients with bipolar I disorder, with or without comorbidity with substance use disorder.
    Sani G, Kotzalidis GD, Vöhringer P, Pucci D, Simonetti A, Manfredi G, Savoja V, Tamorri SM, Mazzarini L, Pacchiarotti I, Telesforo CL, Ferracuti S, Brugnoli R, Ambrosi E, Caloro M, Del Casale A, Koukopoulos AE, Vergne DE, Girardi P, Ghaemi SN.
    J Clin Psychopharmacol; 2013 Apr 19; 33(2):231-5. PubMed ID: 23422396
    [Abstract] [Full Text] [Related]

  • 20. Treatment of acute mania.
    Oral TE.
    Neuro Endocrinol Lett; 2005 Aug 19; 26 Suppl 1():9-25. PubMed ID: 16361986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.